BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/20.09.24 Stock

Warrant

DE000VM7NVS4

Delayed Deutsche Boerse AG 08:03:41 2024-07-11 am EDT
1.8 EUR +4.05% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/20.09.24
Current month-16.83%
1 month-34.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 1.8 +4.05%
24-07-10 1.73 +0.58%
24-07-09 1.72 +0.58%
24-07-08 1.71 -2.84%
24-07-05 1.76 +4.14%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 08:03 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NVS
ISINDE000VM7NVS4
Date issued 2023-12-29
Strike 330 $
Maturity 2024-09-20 (71 Days)
Parity 10 : 1
Emission price 1.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.51
Lowest since issue 1.23
Spread 0.03
Spread %1.55%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
337.3 USD
Average target price
372.4 USD
Spread / Average Target
+10.40%
Consensus